Edwards Lifesciences Corp. (EW)
105.80
-0.01
(-0.01%)
USD |
NYSE |
Nov 12, 16:00
105.89
+0.09
(+0.09%)
Pre-Market: 20:00
Edwards Lifesciences Free Cash Flow (Quarterly) : 506.70M for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 506.70M |
| June 30, 2026 | 585.00M |
| March 31, 2026 | -21.10M |
| December 31, 2025 | 353.50M |
| September 30, 2025 | 516.20M |
| June 30, 2025 | 240.90M |
| March 31, 2025 | 224.40M |
| December 31, 2024 | -181.90M |
| September 30, 2024 | 294.50M |
| June 30, 2024 | 286.10M |
| March 31, 2024 | -138.80M |
| December 31, 2023 | 48.30M |
| September 30, 2023 | 356.20M |
| June 30, 2023 | -27.60M |
| March 31, 2023 | 252.60M |
| December 31, 2022 | 193.70M |
| September 30, 2022 | 250.00M |
| June 30, 2022 | 289.10M |
| March 31, 2022 | 220.60M |
| December 31, 2021 | 279.80M |
| September 30, 2021 | 471.20M |
| June 30, 2021 | 456.80M |
| March 31, 2021 | 194.50M |
| December 31, 2020 | 286.50M |
| September 30, 2020 | 112.80M |
| Date | Value |
|---|---|
| June 30, 2020 | 122.90M |
| March 31, 2020 | 124.80M |
| December 31, 2019 | 327.90M |
| September 30, 2019 | 361.20M |
| June 30, 2019 | 269.40M |
| March 31, 2019 | -57.50M |
| December 31, 2018 | 235.40M |
| September 30, 2018 | 257.20M |
| June 30, 2018 | 87.40M |
| March 31, 2018 | 105.10M |
| December 31, 2017 | 312.00M |
| September 30, 2017 | 267.50M |
| June 30, 2017 | 136.00M |
| March 31, 2017 | 109.70M |
| December 31, 2016 | 137.90M |
| September 30, 2016 | 157.60M |
| June 30, 2016 | 153.20M |
| March 31, 2016 | 79.40M |
| December 31, 2015 | 66.30M |
| September 30, 2015 | 176.50M |
| June 30, 2015 | 151.70M |
| March 31, 2015 | 52.50M |
| December 31, 2014 | 58.70M |
| September 30, 2014 | -5.90M |
| June 30, 2014 | 762.00M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 1.111B |
| Stryker Corp. | 1.224B |
| Abbott Laboratories | 1.224B |
| Boston Scientific Corp. | 868.00M |
| Glaukos Corp. | 36.49M |